NAV

N,O-didansyl-L-tyrosine

Identification

Generic Name
N,O-didansyl-L-tyrosine
DrugBank Accession Number
DB03157
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 647.761
Monoisotopic: 647.175991805
Chemical Formula
C33H33N3O7S2
Synonyms
Not Available
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UThymidylate synthaseNot AvailableEscherichia coli (strain K12)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
Phenylalanine and derivatives
Alternative Parents
1-naphthalene sulfonamides / 1-naphthalene sulfonates / 1-naphthalene sulfonic acids and derivatives / Phenylpropanoic acids / Amphetamines and derivatives / Arylsulfonic acids and derivatives / Phenoxy compounds / Dialkylarylamines / Organosulfonic acid esters / Organosulfonamides
show 8 more
Substituents
1-naphthalene sulfonamide / 1-naphthalene sulfonate / 1-naphthalene sulfonic acid or derivatives / 3-phenylpropanoic-acid / Amine / Amino acid / Aminosulfonyl compound / Amphetamine or derivatives / Aromatic homopolycyclic compound / Arylsulfonic acid or derivatives
show 27 more
Molecular Framework
Aromatic homopolycyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
LUBOPDUYHWABFG-NDEPHWFRSA-N
InChI
InChI=1S/C33H33N3O7S2/c1-35(2)29-13-5-11-26-24(29)9-7-15-31(26)44(39,40)34-28(33(37)38)21-22-17-19-23(20-18-22)43-45(41,42)32-16-8-10-25-27(32)12-6-14-30(25)36(3)4/h5-20,28,34H,21H2,1-4H3,(H,37,38)/t28-/m0/s1
IUPAC Name
(2S)-3-[4-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}oxy)phenyl]-2-[5-(dimethylamino)naphthalene-1-sulfonamido]propanoic acid
SMILES
[H]N([C@@H](CC1=CC=C(OS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C)C=C1)C(O)=O)S(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C

References

General References
Not Available
PubChem Compound
446468
PubChem Substance
46506313
ChemSpider
393811
BindingDB
50161779
ChEMBL
CHEMBL176072
ZINC
ZINC000024640039
PDBe Ligand
DDT
PDB Entries
1jg0

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.000995 mg/mLALOGPS
logP3.83ALOGPS
logP3.72Chemaxon
logS-5.8ALOGPS
pKa (Strongest Acidic)2.89Chemaxon
pKa (Strongest Basic)4.9Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count8Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area133.32 Å2Chemaxon
Rotatable Bond Count10Chemaxon
Refractivity174.95 m3·mol-1Chemaxon
Polarizability68.08 Å3Chemaxon
Number of Rings5Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9273
Blood Brain Barrier+0.5763
Caco-2 permeable-0.6279
P-glycoprotein substrateNon-substrate0.5059
P-glycoprotein inhibitor INon-inhibitor0.6607
P-glycoprotein inhibitor IINon-inhibitor0.6063
Renal organic cation transporterNon-inhibitor0.9312
CYP450 2C9 substrateNon-substrate0.7122
CYP450 2D6 substrateNon-substrate0.8092
CYP450 3A4 substrateNon-substrate0.5
CYP450 1A2 substrateNon-inhibitor0.5803
CYP450 2C9 inhibitorNon-inhibitor0.5457
CYP450 2D6 inhibitorNon-inhibitor0.8883
CYP450 2C19 inhibitorNon-inhibitor0.5508
CYP450 3A4 inhibitorNon-inhibitor0.5988
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.5306
Ames testNon AMES toxic0.6218
CarcinogenicityCarcinogens 0.6331
BiodegradationNot ready biodegradable1.0
Rat acute toxicity2.5109 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8672
hERG inhibition (predictor II)Non-inhibitor0.5749
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-00kb-0022309000-30b6cc38256369ab4e64
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00l2-1280009000-0fefca116a6c120a2fdf
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-00di-0920001000-9ebbc5b22a9bfd3aeb33
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0089-0690000000-56a4be488de01cb07518
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00li-1043791000-7d10f80d67a0d93ecaee
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0zmi-0900000000-23502ed413c5870f626b
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-234.9849
predicted
DeepCCS 1.0 (2019)
[M+H]+236.80978
predicted
DeepCCS 1.0 (2019)
[M+Na]+242.5208
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Thymidylate synthase
Kind
Protein
Organism
Escherichia coli (strain K12)
Pharmacological action
Unknown
General Function
Thymidylate synthase activity
Specific Function
Provides the sole de novo source of dTMP for DNA biosynthesis. This protein also binds to its mRNA thus repressing its own translation.
Gene Name
thyA
Uniprot ID
P0A884
Uniprot Name
Thymidylate synthase
Molecular Weight
30479.475 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at December 11, 2021 01:26